The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol

BackgroundPropofol injection pain is an unpleasant experience to patients and its prevalence can be influenced by age and gender. We determined the half maximal effective concentration (EC50) of remifentanil for preventing the microemulsion propofol injection pain in the male and female adult groups...

Full description

Bibliographic Details
Main Authors: Bo-Won Lee, Sang-Hun Kim, Keum-Young So
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2012-12-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kjae-63-504.pdf
_version_ 1818259871964856320
author Bo-Won Lee
Sang-Hun Kim
Keum-Young So
author_facet Bo-Won Lee
Sang-Hun Kim
Keum-Young So
author_sort Bo-Won Lee
collection DOAJ
description BackgroundPropofol injection pain is an unpleasant experience to patients and its prevalence can be influenced by age and gender. We determined the half maximal effective concentration (EC50) of remifentanil for preventing the microemulsion propofol injection pain in the male and female adult groups.MethodsAfter institutional review board approval, a total of 60 patients were assigned into 2 groups depending on their gender: group M (male, 20-65 yr) and group F (female, 20-65 yr). Anesthesia was induced with propofol and remifentanil, by a target-controlled infusion. Target effect-site concentration (Ce) of propofol and remifentanil for the first patient started at 4.0 ug/ml and 4.0 ng/ml. Ce of remifentanil for each subsequent patient was determined by the response of the previous patient by the Dixon's up-and-down method (DUDM) with an interval of 0.2 ng/ml. After equilibration of plasma and effect site remifentanil concentration, propofol was administered, and the pain responses were observed.ResultsThe remifentanil EC50 was 3.8 ± 0.2 and 2.7 ± 0.2 ng/ml in groups M and F, respectively, by DUDM. From Probit regression model, the remifentanil EC50 was 3.7 (3.0-4.3) and 2.7 (1.8-2.9) ng/ml in groups M and F, respectively.ConclusionsThe remifentanil EC50 for preventing the moderate to severe injection pain of propofol was higher in males than in females.
first_indexed 2024-12-12T18:22:20Z
format Article
id doaj.art-cdfab8c090b448cba2b050c6c068d97a
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-12-12T18:22:20Z
publishDate 2012-12-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-cdfab8c090b448cba2b050c6c068d97a2022-12-22T00:16:07ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632012-12-0163650450910.4097/kjae.2012.63.6.5047466The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofolBo-Won Lee0Sang-Hun Kim1Keum-Young So2Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju, Korea.Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju, Korea.Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju, Korea.BackgroundPropofol injection pain is an unpleasant experience to patients and its prevalence can be influenced by age and gender. We determined the half maximal effective concentration (EC50) of remifentanil for preventing the microemulsion propofol injection pain in the male and female adult groups.MethodsAfter institutional review board approval, a total of 60 patients were assigned into 2 groups depending on their gender: group M (male, 20-65 yr) and group F (female, 20-65 yr). Anesthesia was induced with propofol and remifentanil, by a target-controlled infusion. Target effect-site concentration (Ce) of propofol and remifentanil for the first patient started at 4.0 ug/ml and 4.0 ng/ml. Ce of remifentanil for each subsequent patient was determined by the response of the previous patient by the Dixon's up-and-down method (DUDM) with an interval of 0.2 ng/ml. After equilibration of plasma and effect site remifentanil concentration, propofol was administered, and the pain responses were observed.ResultsThe remifentanil EC50 was 3.8 ± 0.2 and 2.7 ± 0.2 ng/ml in groups M and F, respectively, by DUDM. From Probit regression model, the remifentanil EC50 was 3.7 (3.0-4.3) and 2.7 (1.8-2.9) ng/ml in groups M and F, respectively.ConclusionsThe remifentanil EC50 for preventing the moderate to severe injection pain of propofol was higher in males than in females.http://ekja.org/upload/pdf/kjae-63-504.pdfgender identitypainpropofolremifentanil
spellingShingle Bo-Won Lee
Sang-Hun Kim
Keum-Young So
The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol
Korean Journal of Anesthesiology
gender identity
pain
propofol
remifentanil
title The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol
title_full The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol
title_fullStr The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol
title_full_unstemmed The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol
title_short The effect of gender on EC of remifentanil to prevent pain during injection of microemulsion propofol
title_sort effect of gender on ec of remifentanil to prevent pain during injection of microemulsion propofol
topic gender identity
pain
propofol
remifentanil
url http://ekja.org/upload/pdf/kjae-63-504.pdf
work_keys_str_mv AT bowonlee theeffectofgenderonecofremifentaniltopreventpainduringinjectionofmicroemulsionpropofol
AT sanghunkim theeffectofgenderonecofremifentaniltopreventpainduringinjectionofmicroemulsionpropofol
AT keumyoungso theeffectofgenderonecofremifentaniltopreventpainduringinjectionofmicroemulsionpropofol
AT bowonlee effectofgenderonecofremifentaniltopreventpainduringinjectionofmicroemulsionpropofol
AT sanghunkim effectofgenderonecofremifentaniltopreventpainduringinjectionofmicroemulsionpropofol
AT keumyoungso effectofgenderonecofremifentaniltopreventpainduringinjectionofmicroemulsionpropofol